000 | 01938 a2200529 4500 | ||
---|---|---|---|
005 | 20250516122046.0 | ||
264 | 0 | _c20131217 | |
008 | 201312s 0 0 eng d | ||
022 | _a1724-6016 | ||
024 | 7 |
_a10.5301/ejo.5000159 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEl Chehab, Hussam | |
245 | 0 | 0 |
_aEffect of topical pressure-lowering medication on prevention of intraocular pressure spikes after intravitreal injection. _h[electronic resource] |
260 |
_bEuropean journal of ophthalmology _c |
||
300 |
_a277-83 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcetazolamide _xadministration & dosage |
650 | 0 | 4 | _aAdministration, Topical |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
650 | 0 | 4 | _aBrimonidine Tartrate |
650 | 0 | 4 |
_aClonidine _xadministration & dosage |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntraocular Pressure _xdrug effects |
650 | 0 | 4 | _aIntravitreal Injections |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aOphthalmic Solutions |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aQuinoxalines _xadministration & dosage |
650 | 0 | 4 | _aRanibizumab |
650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
650 | 0 | 4 |
_aThiophenes _xadministration & dosage |
650 | 0 | 4 |
_aTimolol _xadministration & dosage |
650 | 0 | 4 | _aTonometry, Ocular |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
700 | 1 | _aLe Corre, Anne | |
700 | 1 | _aAgard, Emilie | |
700 | 1 | _aRact-Madoux, Guillaume | |
700 | 1 | _aCoste, Olivier | |
700 | 1 | _aDot, Corinne | |
773 | 0 |
_tEuropean journal of ophthalmology _gvol. 23 _gno. 3 _gp. 277-83 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.5301/ejo.5000159 _zAvailable from publisher's website |
999 |
_c22272917 _d22272917 |